Time to rethink pre-emptive interventions for infants with early signs of autism spectrum disorder

Affiliations

¹ Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA. Electronic address: kasari@gseis.ucla.edu.

Comment

Connie Kasari. Lancet Child Adolesc Health. 2019 Sep.

. 2019 Sep;3(9):586-587.

doi: 10.1016/S2352-4642(19)30234-2. Epub 2019 Jul 16.

¹ Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA. Electronic address: kasari@gseis.ucla.edu.

No abstract available

Comment on

Pre-emptive intervention versus treatment as usual for infants showing early behavioural risk signs of autism spectrum disorder: a single-blind, randomised controlled trial.
Whitehouse AJO, Varcin KJ, Alvares GA, Barbaro J, Bent C, Boutrus M, Chetcuti L, Cooper MN, Clark A, Davidson E, Dimov S, Dissanayake C, Doyle J, Grant M, Iacono T, Maybery M, Pillar S, Renton M, Rowbottam C, Sadka N, Segal L, Slonims V, Taylor C, Wakeling S, Wan MW, Wray J, Green J, Hudry K. Whitehouse AJO, et al. Lancet Child Adolesc Health. 2019 Sep;3(9):605-615. doi: 10.1016/S2352-4642(19)30184-1. Epub 2019 Jul 16. Lancet Child Adolesc Health. 2019. PMID: 31324597 Clinical Trial.